This site is intended for Healthcare Professionals.

Menu

Close

HomeShelf Life & StorageDosing & Administration12 years of age and older5 through 11 years of ageSafety & EfficacyResources

WEBSITE TERMS OF USE


Welcome to the COVID-19 mRNA Vaccine BNT162b2 website. This website belongs to Pfizer Limited (“Pfizer”).
Please read and review these Terms of Use carefully before accessing or using this website. By accessing or using this site, you acknowledge that you have read, understood and agreed to these Terms of Use. If you do not agree to the Terms of Use, you may not access or use the website.

Pfizer may alter these Terms of Use from time to time, so you should periodically check these Terms of Use as any changes will take effect as soon as they are posted to this website.


1. Permitted Users.
This site is intended for Healthcare Professionals and Other Relevant Decision Makers resident in the Georgia only. The term ‘Healthcare Professional’ includes members of the medical, pharmacy and nursing professions and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine. The term ‘Other Relevant Decision Makers’ particularly includes those with an NCDC role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.

2. Use of Website.
This website contains information about COVID-19 mRNA Vaccine BNT162b2 including about its preparation, administration and use. The website may also contain information about COVID-19 disease caused by SARS-CoV-2 virus condition and its treatment. Materials on this website that have been identified for patients must be downloaded and used with your patients outside of this website. You may freely browse this website, but you may only access or download material on this website for your personal, non-commercial use. Your access to and use of the information contained in the website is subject to these Terms of Use. You agree to act lawfully at all times in using and accessing this website and you will not do anything which damages, interferes with, disrupts access to, interrupts or impairs the functionality of this website or inhibits other users’ use and enjoyment of the site.

3. Content.
You agree that access to and use of this website and its content is at your own risk. Pfizer may add, alter or delete materials from this website at any time at its discretion. Pfizer will use reasonable efforts to include accurate and up-to-date information on this website but gives no warranties, undertakings or representations of any kind as to its accuracy, currency, quality, completeness or fitness for purpose. Pfizer disclaims all warranties, express or implied to the fullest extent permitted by law. Neither Pfizer, its affiliates, nor any party involved in creating, producing or delivering this website shall be liable for any loss, damage or cost whatsoever, whether in contract, tort (including negligence) or otherwise arising from reliance on information contained in this website, access to, use of, or inability to use this website, or any errors or omissions in its content. This limitation includes any loss, damage or cost caused by any viruses that infect your computer equipment, software or data.

​​​​​​​4. Cookies and Privacy.
Pfizer respects the privacy of its website users. Please refer to our Cookie Policy and Privacy Policy which explains users' rights and the basis on which we may use any personal data (including by using “cookies”) that is disclosed to us via this website.

5. Third Party Websites and Links.
This website may contain links or references to other websites maintained by third parties over whom we have no control. Such links are provided merely as a convenience. Similarly, this website may be accessed from third party links over which Pfizer has no control. Pfizer makes no warranties, undertakings or representations of any kind as to the accuracy, currency, quality, completeness or fitness for purpose of any information contained in such websites and shall have no liability for any loss, damage or cost of any kind arising from such information. Inclusion of any third party link does not imply an endorsement or recommendation by Pfizer.

6. Medical Information.
This website may contain information relating to various medical conditions and their treatment. For those which do, this information is provided for general information only and is not meant to be a substitute for advice provided by a doctor or other qualified healthcare professional. You should not use the information in this website to diagnose a health or fitness problem or disease - always consult with a doctor or other qualified healthcare professional.

7. Non-Confidential Information.
Subject to our Cookie and Privacy Policy, any communication or other material that you send to Pfizer through the internet or post on the website by electronic mail or otherwise, such as any questions, comments and suggestions, is and will be deemed to be non-confidential and Pfizer shall have no obligation of any kind with respect to it. Pfizer shall be free to use any ideas, concepts, know-how or techniques contained in these communications and materials for any purpose whatsoever, including but not limited to, developing, manufacturing and marketing products.

8. Intellectual Property Rights.
Pfizer owns all copyright, patents, database rights, trade marks, designs, know-how and confidential information (whether registered or not), and all other intellectual property rights existing in this website and its contents. The contents of this website may only be copied for non-commercial individual reference with all copyright or other proprietary notices retained, and thereafter may not be recopied, reproduced or otherwise redistributed. Except as expressly permitted above, you may not copy, display, download, distribute, modify, reproduce, republish or retransmit any information, text or documents contained in this website or any part of it in any electronic medium or in hard copy, or create any derivative work based on it, without Pfizer’s express written consent. In addition, the Pfizer name and logo are registered trademarks, and may not be used without Pfizer’s written permission. The misuse of Pfizer’s trademarks or any other materials is prohibited and may be in breach of copyright law, trademark law and/or other English laws. Please note that Pfizer actively and aggressively enforces its intellectual property rights to the fullest extent of the law.

9. Georgia Laws.
This website and its contents are intended to comply with Georgia laws. Although the information on this website is accessible to users outside of the Georgia, the information on the website is intended for use only by Georgia residents. Other countries may have laws, regulatory requirements and medical practices that differ from those in the Georgia. These Terms of Use and your use of the website shall be governed by and construed in accordance with the laws of Georgia. The Georgian courts shall have exclusive jurisdiction over any disputes arising in connection with this website.

10. Miscellaneous.
To the extent that any provisions of these Terms of Use are held to be illegal, invalid or unenforceable, then such provisions shall be severed and deleted without affecting the enforceability of the remaining provisions.

​​​​​​​Copyright © 2017-2020 Pfizer Limited. All rights reserved.

For more information ​​​​​​​

PfizerMedicalInformation.com

Contact

                                                               EUA Fact Sheet Updates
 ​​​​​​​

EUA Fact Sheet Updates
Please be aware that Pfizer-BioNTech COVID-19 Vaccine  (also known as COMIRNATY® (COVID-19 Vaccine, mRNA) is now available in three formulations. For additional information on differences across age groups and formulations please see Vaccine Formulations Guide on the home page of this website.



Label Update: Effective 03 Jan 2022

2.3 Vaccination Schedule

A single Pfizer‑BioNTech COVID-19 Vaccine booster dose (0.3 mL) may be administered at least 5 months after completing a primary series of the Pfizer-BioNTech COVID-19 Vaccine to individuals 12 years of age and older.

A third primary series dose of the Pfizer-BioNTech COVID-19 Vaccine supplied in multiple dose vials with orange caps and labels with orange borders (0.2 mL) at least 28 days following the second dose is authorized for administration to individuals 5 through 11 years of age who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

Click below to view:
    •    EUA Fact Sheet for Vaccination Providers
- 12 year of age and older Dilute Before Use, Purple Cap
    •    EUA Fact Sheet for Vaccination Providers - 12 years of age and older Do Not Dilute, Gray Cap
    •    EUA Fact Sheet for Vaccination Providers - 5 through 11 years of age Dilute Before Use, Orange Cap​​​​​​​

For healthcare professionals only*

The information contained on this site is reserved exclusively for healthcare professionals resident in Georgia. 

I confirm that I am a healthcare professional resident in Georgia*


I accept and agree to the Terms of Use*

Not a Healthcare Professional in Georgia? This website is not intended for patients or for members of the general public.